Skip to content

Premier Biomedical Inc BIEI Stock Analysis

  • PINK
  • Stock
  • Market closed · opens Monday 9:30 AM ET

$0.00 down $0.00, 15.38% at close Oct 14

Last close · Previous close $0.00

Market cap
At the Oct 14 close
P/E ratio
On last 12 months’ EPS
Diluted EPS
Last 12 months
Dividend yield
Last 12 months

Price chart

$0.00down $0.00, 7.69%Wed, Oct 14 session

Use the left and right arrow keys to move along the chart.

Chart period
IEX trades, regular session · Times in ET
Price data

Trading

At last close

  • Previous close$0.00Oct 13
Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

Performance

Valuation

Financials

Dividends

About Premier Biomedical Inc

Premier Biomedical, Inc. is a research-based company. The Company intends to discover and develop medical treatments for humans, targeting the treatment of: alzheimer's disease (AD), fibromyalgia, multiple sclerosis (MS), traumatic brain injury (TBI), amyotrophic lateral sclerosis (ALS/Lou Gehrig's Disease), blood sepsis and viremia, and cancer. The Company intends to develop its drug candidate Feldetrex, which is a treatment for multiple sclerosis, fibromyalgia, and traumatic brain injury. The Company intends to develop its Sequential-Dialysis Technique. The Company's Sequential-Dialysis Technique is a methodology for the removal of those molecules, which are harmful and responsible for causing diseases. The Company has one pending patent application for its Feldetrex candidate drug. Feldetrex may serve as an additional medication utilized by physicians for the treatment of Multiple Sclerosis, Fibromyalgia, or Traumatic Brain Injury.

Sector
Industry
Headquarters
Exchange
PINK
Asset type
Common stock
Price history since

BIEI news

BIEI stock FAQ

What is BIEI stock’s price today?

Premier Biomedical (BIEI) traded at $0.00 at the close on , unchanged from the previous close of $0.00.

What exchange does BIEI trade on?

Premier Biomedical trades on the PINK under the ticker symbol BIEI. Its price history on this dashboard begins on .

Member SIPC.Low CommissionsLearn More (opens in a new tab)

Sponsored. Affiliate link: I may earn a commission. The inclusion of Interactive Brokers’ (IBKR) name, logo or weblink is present pursuant to an advertising arrangement only. IBKR is not a contributor, reviewer, provider or sponsor of content published on this site, and is not responsible for the accuracy of any products or services discussed.

About this data. Data sourced by Tiingo (opens in a new tab). The live price is Tiingo’s real-time price, based on IEX trades and quotes; intraday charts show IEX trades, and volume figures are consolidated totals for completed sessions. Prices are split-adjusted, and total returns assume dividends are reinvested. Financials come from company filings and can lag new reports. Times are Eastern.

This page is for education, not investment advice. Past performance doesn't predict future returns. Logos provided by Logo.dev (opens in a new tab).

The Interactive Brokers word and logo are trademarks of Interactive Brokers LLC (or its subsidiaries) in the US and/or elsewhere. All rights reserved.

Contact Ryan

Get in touch

Contact Me

Have a question or want to work together? Fill out the form below and we'll get back to you as soon as possible.

Contact Form Demo

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.